Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts

Guilin Tang1, Franciose Truong, Oluwole Fadare

  • 1Department of Pathology, UMass Memorial Medical Center, University of Massachusetts School of Medicine Worcester, MA, USA.

Insights

Diagnosing rare myeloid/natural killer (NK) cell leukemia requires advanced flow cytometry. This study highlights key surface markers for distinguishing this leukemia variant from acute promyelocytic leukemia and other preleukemic conditions.

Area of Science:

  • Hematology
  • Immunophenotyping
  • Flow Cytometry

Background:

  • Myeloid/natural killer (NK) cell leukemia is a rare hematologic malignancy.
  • Its distinct morphological and immunophenotypical features present diagnostic challenges.
  • Accurate classification is crucial for appropriate patient management.

Purpose of the Study:

  • To illustrate the importance of advanced flow cytometric immunophenotyping.
  • To highlight the role of updated surface marker understanding in diagnosing myeloid/NK cell leukemia.
  • To differentiate this rare leukemia subtype from other hematologic disorders.

Main Methods:

  • Analysis of two diagnostically challenging cases of myeloid/NK cell leukemia.
  • Utilized advanced flow cytometry for detailed immunophenotyping.
  • Focused on specific surface marker expression (CD11a, CD18, CD117, CD9, HLA-DR, CD34).

Main Results:

  • Case 1: De novo myeloid/NK cell acute leukemia mimicked acute promyelocytic leukemia (APL) but was distinguished by CD11a, CD18, CD117, and CD9 expression.
  • Identified a surrogate surface phenotype (HLA-DR(low), CD11a(low), CD18(low)) for ruling in/out APL.
  • Case 2: Myeloid/NK cell blasts presented in refractory anemia with excess blasts-1 (RAEB-1), characterized by negativity for CD34, CD117, and HLA-DR.

Conclusions:

  • Advanced flow cytometry and updated surface marker knowledge are essential for diagnosing myeloid/NK cell leukemia.
  • Specific immunophenotypic profiles aid in differentiating this rare leukemia from APL and RAEB-1.
  • Accurate classification of preleukemic diseases relies on recognizing these distinct blast variants.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...